SCR-LIP-000564 · Claim · machine-readable JSON →
Using the validated Lipedema Screening Questionnaire (LSQ), probable lipedema was detected in 36.8% of women with lower extremity pain versus 12.3% of controls (p=0.001), and high-probability lipedema in 19.1% vs 3.1% (p=0.003), though the authors caution the LSQ is not diagnostic.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Screening for lipedema in women with lower extremity pain and its associations with functional status, pain, mood, and quality of life: A questionnaire-based case–control study (2026) ✓ verified — consistent · cross sectional · 2026 · reading confidence: high
“Mulheres com dor em membros inferiores tiveram escores de LSQ maiores e mais lipedema provável que controles (36,8% contra 12,3%; p = 0,001)”
The study uses a validated screening questionnaire (LSQ) to identify probable lipedema cases at different frequencies between groups, directly demonstrating that a screening tool can help identify lipedema cases, while noting it is not diag
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000038
- 2026-11-20 — consolidated · SQ-LIP-000038: evidence moved to SCR-LIP-000768